{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:45:17Z","timestamp":1755218717093,"version":"3.43.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jns.2025.123594","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:06:13Z","timestamp":1750878373000},"page":"123594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The clinical burden of Friedreich ataxia in the United States: A retrospective claims database analysis"],"prefix":"10.1016","volume":"475","author":[{"given":"Susan","family":"Perlman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Setyawan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Boudreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seemi","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123594_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123594_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.01.010","article-title":"Friedreich\u2019s ataxia: pathology, pathogenesis, and molecular genetics","volume":"303","author":"Koeppen","year":"2011","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2008.05.009","article-title":"Health related quality of life measures in Friedreich Ataxia","volume":"272","author":"Epstein","year":"2008","journal-title":"J. Neurol. Sci."},{"issue":"14","key":"10.1016\/j.jns.2025.123594_bb0020","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.94.14.7452","article-title":"Evolution of the Friedreich\u2019s ataxia trinucleotide repeat expansion: founder effect and premutations","volume":"94","author":"Coss\u00e9e","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2025.123594_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jnc.12215","article-title":"Prevalence gradients of Friedreich\u2019s ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge","volume":"126","author":"Vankan","year":"2013","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0030","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","article-title":"Consensus clinical management guidelines for Friedreich ataxia","volume":"9","author":"Corben","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2025.123594_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-015-0328-4","article-title":"Friedreich ataxia in Norway\u2013an epidemiological, molecular and clinical study","volume":"10","author":"Wedding","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13023-020-01475-9","article-title":"Onset features and time to diagnosis in Friedreich\u2019s ataxia","volume":"15","author":"Indelicato","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"issue":"5","key":"10.1016\/j.jns.2025.123594_bb0045","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s12311-024-01687-w","article-title":"Prevalence and diagnostic journey of Friedreich\u2019s ataxia in the state of S\u00e3o Paulo, Brazil","volume":"23","author":"Machado","year":"2024","journal-title":"Cerebellum"},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-009-1002-3","article-title":"Friedreich ataxia: the clinical picture","volume":"256","author":"Pandolfo","year":"2009","journal-title":"J. Neurol."},{"issue":"14","key":"10.1016\/j.jns.2025.123594_bb0055","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1212\/WNL.0000000000200913","article-title":"Natural history of Friedreich\u2019s ataxia: heterogeneity of neurological progression and consequences for clinical trial design","volume":"99","author":"Rummey","year":"2022","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jns.2025.123594_bb0060","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s004399900142","article-title":"G130V, a common FRDA point mutation, appears to have arisen from a common founder","volume":"105","author":"Delatycki","year":"1999","journal-title":"Hum. Genet."},{"issue":"16","key":"10.1016\/j.jns.2025.123594_bb0065","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jns.2025.123594_bb0070","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1177\/0883073812448230","article-title":"Clinical features of Friedreich Ataxia","volume":"27","author":"Delatycki","year":"2012","journal-title":"J. Child Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2025.123594_bb0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jnc.12317","article-title":"Clinical features of Friedreich\u2019s ataxia: classical and atypical phenotypes","volume":"126","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.jns.2025.123594_bb0080","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1302\/0301-620X.94B5.28391","article-title":"Scoliosis in patients with Friedreich\u2019s ataxia","volume":"94","author":"Tsirikos","year":"2012","journal-title":"J. Bone Joint Surg. (Br.)"},{"issue":"2","key":"10.1016\/j.jns.2025.123594_bb0085","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.neuroscience.2010.09.013","article-title":"Successful treatment of auditory perceptual disorder in individuals with Friedreich ataxia","volume":"171","author":"Rance","year":"2010","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.jns.2025.123594_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11136-019-02311-9","article-title":"Health-related quality of life and depressive symptoms in Friedreich ataxia","volume":"29","author":"P\u00e9rez-Flores","year":"2020","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijchp.2017.11.004","article-title":"Depressive symptoms in Friedreich ataxia","volume":"18","author":"Nieto","year":"2018","journal-title":"Int. J. Clin. Health Psychol."},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/bmb\/ldx034","article-title":"Friedreich\u2019s ataxia: clinical features, pathogenesis and management","volume":"124","author":"Cook","year":"2017","journal-title":"Br. Med. Bull."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123594_bb0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2025.123594_bb0110","unstructured":"Recent advances in Friedreich ataxia management. Am. J. Manag. Care. October 10, 2023. Accessed on: December 17, 2023. Available from: https:\/\/www.ajmc.com\/view\/recent-advances-in-friedreich-ataxia-management#."},{"issue":"11","key":"10.1016\/j.jns.2025.123594_bb0115","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1001\/jamaneurol.2015.1855","article-title":"A 22-year follow-up study of long-term cardiac outcome and predictors of survival in Friedreich ataxia","volume":"72","author":"Pousset","year":"2015","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.jns.2025.123594_bb0120","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40265-023-01874-9","article-title":"Omaveloxolone: first approval","volume":"83","author":"Lee","year":"2023","journal-title":"Drugs"},{"author":"United States Food and Drug Administration","key":"10.1016\/j.jns.2025.123594_bb0125"},{"issue":"2","key":"10.1016\/j.jns.2025.123594_bb0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2025.123594_bb0135","doi-asserted-by":"crossref","unstructured":"Powell L, Lynch D, Qian C, Salvucci A, Vasco G, Johnston KM, et al. RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States. Value in Health, 2023, 26(6): S379.","DOI":"10.1016\/j.jval.2023.03.2128"},{"issue":"3","key":"10.1016\/j.jns.2025.123594_bb0140","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.29687","article-title":"Predictors of survival in Friedreich\u2019s ataxia: a prospective cohort study","volume":"39","author":"Indelicato","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2025.123594_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.11.006","article-title":"Predictors of loss of ambulation in Friedreich\u2019s ataxia","volume":"18","author":"Rummey","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jns.2025.123594_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109828","article-title":"Friedreich\u2019s ataxia related diabetes: epidemiology and management practices","volume":"186","author":"Tamaroff","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"s1","key":"10.1016\/j.jns.2025.123594_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/jnc.12216","article-title":"Diabetes in Friedreich ataxia","volume":"126","author":"Cnop","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2025.123594_bb0160","series-title":"Diabetes Associated With Single Gene Defects and Chromosomal Abnormalities","first-page":"0","article-title":"Diabetes in Friedreich ataxia","volume":"25","author":"Ran","year":"2017"},{"issue":"9","key":"10.1016\/j.jns.2025.123594_bb0165","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/acn3.439","article-title":"Impact of diabetes in the Friedreich ataxia clinical outcome measures study","volume":"4","author":"McCormick","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2025.123594_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000201598","article-title":"Patient-reported impact of symptoms in Friedreich ataxia","volume":"100","author":"Seabury","year":"2023","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2025.123594_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116396","article-title":"The pathogenesis of cardiomyopathy in Friedreich ataxia","volume":"10","author":"Koeppen","year":"2015","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jns.2025.123594_bb0185","first-page":"34","article-title":"Geographic and socio-demographic features of Friedreich ataxia: implications for clinical research","volume":"4","author":"Isaacs","year":"2016","journal-title":"J. Rare Dis."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T09:41:47Z","timestamp":1754473307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"alternative-id":["S0022510X25002114"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123594","relation":{},"ISSN":["0022-510X"],"issn-type":[{"type":"print","value":"0022-510X"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical burden of Friedreich ataxia in the United States: A retrospective claims database analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123594","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123594"}}